Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer

FEBS Open Bio. 2020 Jan;10(1):147-157. doi: 10.1002/2211-5463.12765. Epub 2019 Dec 3.

Abstract

Epstein-Barr virus (EBV)-associated gastric cancer (GC) is associated with a high degree of DNA methylation. However, the association between chemotherapy susceptibility and tumor DNA methylation in advanced diseases remains unclear. The comprehensive DNA methylation status of GC cells obtained from an advanced EBV-associated GC (EBVGC) case, in which complete response to S-1 plus cisplatin chemotherapy was achieved, was analyzed using a DNA methylation microarray. We compared DNA methylation of GC cells with public data and identified genes with higher methylation in EBVGC cell lines than in normal gastric cells, and genes in which methylation was increased by EBV. Of these genes, ABCG2, AHNAK2, BCL2, FZD1, and TP73 are associated with published evidence for resistance to 5-fluorouracil and cisplatin. Silencing of these genes may be associated with hypersensitivity to chemotherapy.

Keywords: DNA methylation; EBV; Epstein-Barr virus-associated gastric cancer; chemotherapy; drug susceptibility; gastric cancer.

Publication types

  • Case Reports

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / genetics
  • Antineoplastic Agents / pharmacology
  • Cell Line
  • Cisplatin / pharmacology
  • Cytoskeletal Proteins / genetics
  • DNA Methylation* / drug effects
  • DNA Methylation* / genetics
  • DNA, Neoplasm / drug effects
  • DNA, Neoplasm / genetics*
  • Drug Combinations
  • Drug Resistance, Neoplasm / drug effects
  • Drug Resistance, Neoplasm / genetics*
  • Fluorouracil / pharmacology
  • Frizzled Receptors / genetics
  • Gene Silencing / drug effects
  • Herpesvirus 4, Human / drug effects
  • Herpesvirus 4, Human / pathogenicity*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins / genetics
  • Oligonucleotide Array Sequence Analysis
  • Oxonic Acid / pharmacology
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / virology
  • Tegafur / pharmacology
  • Tumor Protein p73 / genetics

Substances

  • ABCG2 protein, human
  • AHNAK2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Antineoplastic Agents
  • BCL2 protein, human
  • Cytoskeletal Proteins
  • DNA, Neoplasm
  • Drug Combinations
  • FZD1 protein, human
  • Frizzled Receptors
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • TP73 protein, human
  • Tumor Protein p73
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Cisplatin
  • Fluorouracil